Schistosoma: Difference between revisions

From IDWiki
Schistosoma
Content deleted Content added
mNo edit summary
No edit summary
Line 5: Line 5:
===Microbiology===
===Microbiology===


*''[[Schistosoma mansoni]]'': liver and gut
*[[Schistosoma mansoni]]: liver and gut
*''[[Schistosoma haematobium]]'': GU/pelvis
*[[Schistosoma haematobium]]: GU/pelvis
*''[[Schistosoma japonicum]]'': liver and gut
*[[Schistosoma japonicum]]: liver and gut
*''[[Schistosoma mekongi]]'': Mekong basin
*[[Schistosoma mekongi]]: Mekong basin


===Risk Factors===
===Risk Factors===
Line 15: Line 15:


=== Epidemiology ===
=== Epidemiology ===
{| class="wikitable"

!Region
* Seroprevalence in migrants by region of origin[[CiteRef::asundi2019pr]]
!Species
** Latin America and the Caribbean (20%; 9-34)
!Seroprevalence in Migrants[[CiteRef::asundi2019pr]]
** Middle East and north Africa (6.4%; 0.3-19.5)
|-
** Sub-Saharan Africa (24.1%; 16-33)
|Latin America and the Caribbean
** South Asia (0%; 0-69)
|[[Schistosoma mansoni]] (Brazil, Venezuela, Suriname, Caribbean)
** East Asia and the Pacific (5.4%; 2-10)
|20%
|-
|Middle East and northern Africa
|[[Schistosoma haematobium]][[Schistosoma mansoni]] (sporadic reports in Arabian Peninsula)
|6%
|-
|Sub-Saharan Africa
|[[Schistosoma mansoni]][[Schistosoma haematobium]][[Schistosoma intercalatum]] (DRC)
[[Schistosoma guineensis]] (West Africa)
|24%
|-
|South Asia
|None
|0%
|-
|East Asia and the Pacific
|[[Schistosoma japonicum]] (China, Philippines, Sulawesi)
[[Schistosoma mekongi]] (Cambodia, Laos)
|5%
|}


==Clinical Manifestations==
==Clinical Manifestations==

Revision as of 15:05, 24 April 2025

Background

  • Infection with a species of the genus Schistosoma

Microbiology

Risk Factors

  • Fresh water exposure in endemic countries

Epidemiology

Region Species Seroprevalence in Migrants1
Latin America and the Caribbean Schistosoma mansoni (Brazil, Venezuela, Suriname, Caribbean) 20%
Middle East and northern Africa Schistosoma haematobiumSchistosoma mansoni (sporadic reports in Arabian Peninsula) 6%
Sub-Saharan Africa Schistosoma mansoniSchistosoma haematobiumSchistosoma intercalatum (DRC)

Schistosoma guineensis (West Africa)

24%
South Asia None 0%
East Asia and the Pacific Schistosoma japonicum (China, Philippines, Sulawesi)

Schistosoma mekongi (Cambodia, Laos)

5%

Clinical Manifestations

Swimmer's Itch

  • Cercariae penetrate exposed skin and cause prickling sensation and occasionally urticaria, followed hours later by a macular rash
  • Caused by schistosomes that do not cause systemic illness
  • Common in Great Lakes region of North America, New England in the US, and other parts of North America and Europe

Katayama Fever

  • Syndrome of acute schistosomiasis that follows 4 to 8 weeks (range 2 to 12 weeks), after the flukes have migrated, developed into adults, and have started producing eggs
  • The syndrome represents a hypersensitivity reaction to the eggs produced by adult worms
  • More common with Schistosoma japonicum and Schistosoma mansoni, and less common with Schistosoma haematobium
  • Symptoms include abrypt onset of fever, chills, fatigue, headache, myalgias, abdominal pain, diarrhea, and occasionally bloody stool
  • Most also develop cough, dyspnea, chest pain, and diffuse infiltrates on chest x-ray
    • Lung nodules contain granulomas around eggs
  • Hepatomegaly, splenomegaly, and lymphadenopathy are common
  • Eggs may not be seen in stool until later in the course of the disease
  • Symptoms usually resolve within 2 to 10 weeks
  • Can involve symptoms anywhere the worms migrate and deposit eggs: CNS, genital tract, and skin
    • However, an induced small-vessel vasculitis can also cause neurological symptoms

Chronic Schistosomiasis

  • Can be asymptomatic or paucisymptomatic
  • Chronic granulomatous inflammation causes weight loss, anemia, stunted growth
  • Eosinophilia is common

Investigations

  • Labs
    • CBC, showing eosinophilia
    • Schistosoma serology (only positive 6 weeks after infection)
    • Egg detection in stool, urine, semen, or tissue biopsy
  • Imaging
    • Eggs can cause granulomatous disease in various organs
    • Bladder polyps and obstruction may be seen on ultrasound

Diagnosis

  • Usually based on serology
    • Can cross-react with other helminth co-infections, including trichinosis and filariasis
    • Can remain positive and even fluctuate for years after cure2

Management

  • Acute
  • Chronic
    • Praziquantel 20-40 mg/kg or 40-60 mg/kg (if at risk for S. japonica)
    • Given over one day split into 3 doses
    • May be repeated 6 weeks later, though this practice is not universal
    • No role for test-of-cure serology

Prognosis

  • Increased risk of squamous cell carcinoma, which increase with young age at infection, duration of infection, high burden of infection, and bladder wall fibrosis

References

  1. ^  Archana Asundi, Alina Beliavsky, Xing Jian Liu, Arash Akaberi, Guido Schwarzer, Zeno Bisoffi, Ana Requena-Méndez, Ian Shrier, Christina Greenaway. Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. The Lancet Global Health. 2019;7(2):e236-e248. doi:10.1016/s2214-109x(18)30490-x.
  2. ^  Michelle K. Yong, Carolyn L. Beckett, Karin Leder, Beverley A. Biggs, Joseph Torresi, Daniel P. O’Brien. Long‐Term Follow‐Up ofSchistosomiasisSerology Post‐Treatment in Australian Travelers and Immigrants. Journal of Travel Medicine. 2010;17(2):89-93. doi:10.1111/j.1708-8305.2009.00379.x.